Last update 26 Nov 2024

ASN-007

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ASN 007A, ASN-0007, ERAS 007
+ [1]
Mechanism
ERK1 inhibitors(Extracellular-signal-regulated kinase1 inhibitors), ERK2 inhibitors(Extracellular-signal-regulated kinase 2 inhibitors)
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPhase 2
US
15 Mar 2022
Metastatic Colorectal CarcinomaPhase 2
US
20 Sep 2021
Metastatic Pancreatic Ductal AdenocarcinomaPhase 2
US
20 Sep 2021
Advanced Malignant Solid NeoplasmPhase 2
US
07 May 2021
Metastatic Solid TumorPhase 2
US
07 May 2021
Gastrointestinal NeoplasmsPhase 2
US
-
BRAF V600E mutant Colorectal CancerPhase 1
US
20 Sep 2021
Advanced Lung Non-Small Cell CarcinomaPhase 1
US
02 Sep 2021
Advanced Lung Non-Squamous Non-Small Cell CarcinomaPhase 1
US
02 Sep 2021
colon cancer liver metastasisPhase 1
US
19 Jan 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
19
npivnyttcu(hyrkjnjsyx) = 26.3% pclszibvpj (jqngaxtwej )
Positive
24 May 2024
Phase 1/2
12
eurzrsffcb(ymsemstbym) = dyqfhvemri fmcjjtxmoq (vpuyecjryj )
Positive
31 May 2023
Phase 1/2
30
rwibndtzig(foudtmqbqz) = tyhhdgouip erfgbckgvx (xttyexvdnc )
Positive
26 May 2023
Phase 1/2
-
rallegfvbm(xqinyswtfz) = Monitorable and manageable adverse event (AE) profile with mostly grade 1 and 2 treatment-related AEs ijfhgiggft (fqpbkaijre )
Positive
12 Oct 2022
Phase 1
RAS/RAF mutation Solid Tumors
RAS Mutation | RAF Mutation | MEK Mutation
-
ykwnvlhltd(tnepzeaeps) = 40mg QD and 250mg QW,respectively rogzztewfc (ncnuiwvnzw )
Positive
01 Dec 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free